Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2012
02/23/2012CA2808998A1 A novel method for diagnosing q-fever using a cellular immunological test
02/23/2012CA2808859A1 Cancer diagnostic and cancer therapeutic
02/23/2012CA2808809A1 Method for quantitative measurement of gastric acidity using 13c carbonate salt
02/23/2012CA2808760A1 Method for isolating urea while removing undesirable co2
02/23/2012CA2808750A1 Expandable enclosure for oil-in-water analysers
02/23/2012CA2808700A1 In-situ reagent for detection of proteins
02/23/2012CA2808669A1 Sox9 as a marker for aggressive cancer
02/23/2012CA2808668A1 Tam receptors and tam receptor ligands in detection and modulation of neuropathological disease
02/23/2012CA2808625A1 Small molecule arrays and methods for making and using them
02/23/2012CA2808485A1 Methods and means for characterizing antibiotic resistance in microorganisms
02/23/2012CA2808417A1 Circulating biomarkers for disease
02/23/2012CA2807719A1 Microfluidic cell separation in the assay of blood
02/23/2012CA2807209A1 Markers of the male urogenital tract
02/23/2012CA2807104A1 Bard1 isoforms in lung and colorectal cancer and use thereof
02/23/2012CA2806851A1 Anti-human igg1 antibody
02/23/2012CA2802278A1 An assay for measurement of antibodies binding to a therapeutic monoclonal antibody
02/22/2012EP2420845A1 System for generating / collecting, saving and making available data from an electric facility comprising a cooling or working liquid
02/22/2012EP2420844A1 Analytical method of hemoglobin
02/22/2012EP2420843A1 Biomarkers for predicting maintenance of weight loss
02/22/2012EP2420842A1 In vivo imaging of calcified lesions
02/22/2012EP2420841A2 An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
02/22/2012EP2420840A2 An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
02/22/2012EP2420839A2 An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
02/22/2012EP2420838A2 An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
02/22/2012EP2420837A2 An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
02/22/2012EP2420836A2 An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
02/22/2012EP2420835A2 An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
02/22/2012EP2420834A1 Methods and means for diagnosing spondyloarthritis using autoantibody markers
02/22/2012EP2420833A1 T-cell vaccine
02/22/2012EP2420832A1 Cross-species and multi-species display systems
02/22/2012EP2420831A1 Dried blood spotting paper device and method
02/22/2012EP2420830A1 Chloride transporter ClC-7 and cell-based screening method
02/22/2012EP2420829A2 Disease diagnosing biosensor capable of promptly separating blood cells
02/22/2012EP2420824A2 Multi-well plate having an array of wells and kit for use in the conduct of an ECL assay
02/22/2012EP2420823A1 Standoff explosives detector using deep-uv raman spectroscopy
02/22/2012EP2420814A2 Automatic slide processing apparatus and method for processing slides
02/22/2012EP2420576A2 Use of HE4 and other biochemical markers for assessment of ovarian cancers
02/22/2012EP2420575A2 Marker for prognosis of liver cancer
02/22/2012EP2420516A1 Rapid generation of T cell-independent antibody responses to T cell-dependent antigens
02/22/2012EP2420515A1 Diagnosis and treatment of cancer using anti-tmprss11e antibody
02/22/2012EP2420512A2 Anti-VEGF antibodies
02/22/2012EP2420248A1 Mutated HIV NEF for modulating immunity
02/22/2012EP2420190A1 Physiologically active substance collecting device
02/22/2012EP2419945A1 Selective ion transport device
02/22/2012EP2419742A1 Detecting phospholipidosis and diagnosing lysosomal storage disorders
02/22/2012EP2419741A1 Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin
02/22/2012EP2419740A1 Method to detect and sequence post translationally modified peptides
02/22/2012EP2419739A1 Method for quantifying modified peptides
02/22/2012EP2419738A1 Alzheimer's disease
02/22/2012EP2419737A2 Histone modification patterns for clinical diagnosis and prognosis of cancer
02/22/2012EP2419736A1 Methods of assessing activity of a polysaccharide composition
02/22/2012EP2419735A1 Method for determining the cbl-b expression
02/22/2012EP2419734A1 Direct fluorescene immunoassay for viral antigens
02/22/2012EP2419733A2 Methods and devices for detecting the presence of an analyte in a sample
02/22/2012EP2419732A1 Prion-free nanoparticle compositions and methods
02/22/2012EP2419731A1 Biomarkers
02/22/2012EP2419730A1 Method for stimulating antigen-specific t cell responses using accelerated co-cultured dendritic cells
02/22/2012EP2419729A1 A rapid method of pattern recognition, machine learning, and automated genotype classification through correlation analysis of dynamic signals
02/22/2012EP2419728A1 Biomarker for monitoring patients
02/22/2012EP2419727A1 Interferon-alfa sensitivity biomarkers
02/22/2012EP2419726A2 Ensemble-decision aliquot ranking
02/22/2012EP2419725A1 On-board control detection
02/22/2012EP2419712A2 Method and apparatus for multimodal imaging of biological tissue
02/22/2012EP2419541A2 Quality control bioassays for nutriceutical and medicinal products
02/22/2012EP2419534A1 Signature of secreted protein isoforms specific to ovarian cancer
02/22/2012EP2419533A1 Process for tumour characteristic and marker set identification, tumour classification and marker sets for cancer
02/22/2012EP2419529A1 Inflammatory bowel disease prognostics
02/22/2012EP2419526A1 Methods for selecting oocytes and competent embryos with high potential for pregnancy outcome
02/22/2012EP2419512A1 Method of screening for insulin secretion-potentiating agents
02/22/2012EP2419478A2 Fluorescent imaging with substituted cyanine dyes
02/22/2012EP2419451A1 Antibodies against prostate specific membrane antigen
02/22/2012EP2419449A1 B-lymphocyte targeting agents for use in a method for the treatment of a disease
02/22/2012EP2419447A1 Antibodies that specifically bind to a beta oligomers and use thereof
02/22/2012EP2419385A1 System setup for biological methane potential test
02/22/2012EP2419217A1 Microfluidic clinical analyzer
02/22/2012EP2419216A1 Microfluidic device comprising sensor
02/22/2012EP2419177A1 Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
02/22/2012EP2419170A2 Cellular electric stimulation mediated by piezoelectric nanotubes
02/22/2012EP2419111A1 Sensitizing agents for cancer therapy, methods of use and methods for the identification thereof
02/22/2012EP2419024A1 Assaying device
02/22/2012EP2418933A1 Sensing techniques for on-farm analysis of milk components
02/22/2012EP2361988A9 Molecular marker for cancer stem cell
02/22/2012EP2324361B1 Novel method of prognosis associated with cases of postpartum haemorrhage
02/22/2012EP2281195B1 Pro-epil expression level in a biological sample as testicular cancer biomarker, particularly in combination with the hcgbeta and afp biomarkers
02/22/2012EP2232255B1 Method for determining the particulate oxidation rate of particulates retained in a particulate filter
02/22/2012EP2227322B1 Partial derivatization of particles
02/22/2012EP2115455B1 A rapid homogeneous immunoassay using electrophoresis
02/22/2012EP1882937B1 Method for diagnosis of severity and prediction of recurrence in eosinophilic inflammatory disease
02/22/2012EP1805510B1 Therapeutic strategy for treating autoimmune and degenerative diseases
02/22/2012EP1740608B1 Modified human growth hormone polypeptides and their uses
02/22/2012EP1729136B1 Method of agitating solution
02/22/2012EP1697746B1 Risk markers for cardiovascular disease
02/22/2012EP1668156B9 Method of diagnosing breast cancer
02/22/2012EP1643250B1 Biochemical reaction system, biochemical reaction substrate, process for producing hybridization substrate and hybridization method
02/22/2012EP1567007B1 Compositions and methods for cancer diagnosis and therapy
02/22/2012EP1532278B1 Diagnosis of chronic rejection
02/22/2012EP1368632B8 Direct detection of biomolecules in polyacrylamide gel
02/22/2012EP1364065B1 Polynucleotides for use as tags and tag complements, manufacture and use thereof
02/22/2012EP1297334B1 Method of using a flow cytometry-based hematology system
02/22/2012EP1095183B1 Methods for the diagnosis and treatment of lung cancer
1 ... 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 ... 3937